Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 13/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23908832 | 0.91 | S1PR2 (0.64) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23914486 | 0.90 | S1PR2 (0.53) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23908728 | 0.84 | S1PR2 (0.67) | S1PR2GAALMNA | |
| SCHEMBL23909105 | 0.80 | S1PR2 (0.54) | S1PR2 | |
| SCHEMBL23908795 | 0.80 | S1PR2 (0.66) | S1PR2ALOX15 | |
| SCHEMBL23966640 | 0.78 | S1PR2 (0.53) | S1PR2RECQL | |
| SCHEMBL23908889 | 0.71 | S1PR2 (0.93) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23908877 | 0.70 | S1PR2 (1.00) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23908853 | 0.70 | S1PR2 (1.00) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL24076900 | 0.64 | CYP1A2 (0.77) | CYP1A2CYP3A4CYP2C9CYP2C19L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3649119-B1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS | GALAPAGOS NV (BE) | 2021-11-03 | — | — | EP | disclosed |